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Abstract: Due to the presence of numerous bioactive compounds, including 
polysaccharides and polyphenols, mushroom-based food supplements are 
claimed to have many beneficial health effects. Despite their popularity, con-
cerns have been raised in recent years over the quality of mushroom products, 
particularly regarding their non-standardized chemical composition. In this 
study, the β-glucan and total phenolic contents, as well as the antioxidant pot-
ential of mushroom-derived supplements available on the Serbian market were 
analyzed. The obtained results, revealing considerable differences in β-glucan 
and total polyphenol contents among these products, reflect variations in mush-
room species, forms and recommended dosing regimens. A correlation 
between the total phenolic content and antioxidant activity was observed. The 
presence of other active ingredients, such as vitamin C, has contributed to anti-
oxidant variability among the analyzed products. The obtained results indicate 
the need for the standardization of mushroom-derived food supplements to 
ensure their claiming effects. 
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INTRODUCTION 
Mushrooms are widely consumed in many parts of the world due to their 
nutrient contents, as well as the consequently recognized health benefits. Their 
important nutritional value is based on low calories, fat and sodium while being 
quite rich in protein, dietary fiber, vitamins and minerals.1 In addition, mushro-
oms are rich in bioactive secondary metabolites, including polysaccharides, phe-
nolic compounds, glycopeptides, polyketides, terpenoids and saponins.2 Among 
these compounds, the most distinguishable are polysaccharides, which have been 
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extensively studied,3 especially β-glucans with a range of dry matter content of 
15–22 %.4 Unlike the β-glucans present in cereals, which have β-(1→3) (1→4) 
linkages, the β-glucans in the fungal cell wall, mainly contain β-(1→3) (1→6) 
linkages.5 Opposed to β-glucans from yeast, mushroom-derived β-glucans usu-
ally have shorter side chains.6 Beside the degree of branching, other factor such 
as molecular weight, conformation and solubility are factors that have significant 
impacts on its biological activity.7 
Due to the β-glucans content, mushrooms have been shown to have promin-
ent immunomodulatory activities.8 Since these compounds cannot be synthesized 
endogenously, they are recognized by the immune system initiating both adaptive 
and innate immune responses.9 Some mushrooms β-glucans have shown potent 
anticancer properties.10 In addition, there is an increasing body of evidence that 
mushroom β-glucans possess antidiabetic, hypocholesterolemic, antiobesity, anti-
hypertensive, wound healing, hepatoprotective and other beneficial effects.11,12  
Besides polysaccharides, mushrooms contain a wide range of bioactive com-
pounds, including phenolics, tocopherols, carotenoids, glycosides, ergothioneine 
and ascorbic acid,13 which altogether contribute to mushrooms having a higher 
antioxidant potential than most vegetables and fruits have.14  
Therefore, the growing evidence of health-promoting effects of mushroom 
and their compounds has led to increased number of products in the fungi-based 
supplements market.15 These products contain refined, or partially refined ext-
racts, dried fruiting bodies or mycelium, from reishi (Ganoderma lucidum), 
shiitake (Lentinus edodes), maitake (Grifola frondosa), cordyceps (Cordyceps 
sinensis) and Chaga (Inonotus obliquus) in the form of capsules, tablets, powder 
or liquids.16  
In parallel with their popularity, due to the lack of standardization require-
ments, there is a rising concern regarding the effectiveness of these products. 
This in particular could be contributed to economically motivated adulteration 
and intentional substitution of mushroom-derived materials by some less expen-
sive or lower quality ones.16,17 Therefore, the requirement for chemical insights 
into the quality of mushroom supplements, based on the content of bioactive 
compounds, such as polysaccharides, has been recognized.18 However, the qual-
ity of such products has not been the subject of extensive studies. Apart from act-
ing as natural immunity enhancers, these products are also often claimed to be 
antioxidant capacity boosters,19 without giving information related to the anti-
oxidant capacity effectiveness.  
Therefore, the purpose of this study was to evaluate the β-glucan content, as 
well as polyphenol content and antioxidant capacity of mushroom-derived sup-
plements present on the Serbian market. Moreover, the obtained results in the 
recommended daily dose (dd) for each analyzed supplement were compared with 
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serving size of shiitake mushrooms, selected on the evidence for the effectiveness 
of its regular consumption.20 
EXPERIMENTAL 
Standards and reagents 
Trolox (97 %), TPTZ (2,4,6-tris(2-pyridyl)-s-triazine), DPPH (2,2-diphenyl-1-picrylhyd-
razyl), ABTS (2,20-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) were obtained from 
Sigma–Aldrich (St. Luis, MO, USA). Gallic acid (98 % purity) was purchased from Acros 
Organics (Morris Plains, NJ, USA). Folin–Ciocalteu reagent (FC), sodium carbonate, ferric 
chloride hexahydrate, potassium peroxodisulfate, neocuproine and copper(II) chloride were 
supplied by Merck (Darmstadt, Germany). All the reagents were of analytical grade.  
Samples and sample preparations  
Samples (n = 16) were food supplements commercially available in Serbian pharmacies 
and health food stores. Their selection was based on the content of mushroom-derived pre-
parations (powder, extract or isolated compounds), either as a single active component or in 
various combinations. Detailed characteristics of the analyzed supplements, labeled by the 
producer, are presented in Table I. 
Samples, or the contents of the capsules, were weighed (1 g of each) and 10 ml of dis-
tilled water was added. The mixtures were vortexed and after 1 h of extraction in an ultrasonic 
bath (FALC Instruments, Italy), the samples were centrifuged at 3000 rcf for 15 min (Janetzki 
T32C, Wallhausen, Germany). The supernatants were transferred to 50 ml flasks and filled to 
the mark with distilled water. The obtained extracts were immediately analyzed to obtain the 
total phenolic content and antioxidant activities.  
Fresh fruiting bodies of shiitake mushrooms (Lentinula edodes) were purchased at a 
local market. Mushrooms (50 g) were cleaned, mashed and then macerated with 100 ml of 
distilled water at room temperature for 24 h. The mixture was centrifuged at 3000 rcf for 15 
min, and the supernatant was removed and filtered through Whatman No. 1 filter paper. For 
phenolic content and antioxidant activities evaluation, the supernatant was filled to the mark 
obtain 200 ml in a flask.  
Weighed samples of original mushroom supplements (or the content of capsules) and 
shiitake mushroom dried at room temperature were used for determination of β-glucan 
content. 
Determination of the total phenolic content (TPC) 
The total phenolic content was determined using the rapid Folin–Ciocalteu microassay.21 
Reaction mixtures (extracts (10 μL)), ten times diluted Folin– Ciocalteu’s reagent (100 μL) 
and 1M Na2CO3 (80 μL) were incubated in 96-well microplate for 1 h in the dark. The abs-
orbance of the solutions was read at 630 nm on an MTP reader (Biotek, USA, ELx800 118 
absorbance microplate reader). Gallic acid was used to obtain the standard curve and the 
results are expressed as mg of gallic acid equivalents (mg GAE) per g of the weighed samples 
and recommended daily doses for the mushroom-derived supplements and as mg of GAE per 
serving size (72.5 g) for shiitake mushrooms.22  
Determination of antioxidant activity 
Trolox equivalent antioxidant capacity (ABTS/TEAC) radical scavenging microassay. 
The ABTS test was performed using the method proposed by Pastoriza et al.23 Stock solutions 
of ABTS (14 mM) and potassium peroxodisulfate (4.9 mM) in phosphate buffer (pH 7.4) were 
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prepared and mixed in equal volumes. The mixture was left over night at room temperature 
and then diluted with phosphate buffer to achieve an absorbance of 0.7±0.02 at 734 nm. In 
order to determine the scavenging activity, 20 μl aliquots of extracts were mixed with 280 μl 
of the ABTS solution in a 96-well microplate. The absorbance was measured after 6 min at 
630 nm using an MTP reader. A Trolox calibration curve was used for quantification of anti-
oxidant activity. The results are expressed as μM Trolox equivalents (TE) per recommended 
daily doses for the mushroom-derived supplements and as μM TE per serving size for the 
shiitake mushrooms. 
TABLE I. Characteristics of the commercially available mushroom-derived food supplements; 
C – capsule; S – syrup; P – powder 
Code Composition according to the producer Recommended daily dose 
C1 Reishi extract 300 mg (90 mg polysaccharide); vitamin C (acerola 
extract) 6.75 mg 
2 capsules twice 
C2 Cordyceps extract 300 mg (90 mg polysaccharide); vitamin C 
(acerola extract) 6.75 mg 
2 capsules twice 
C3 Shiitake extract 300 mg (90 mg polysaccharide); vitamin C 
(acerola extract) 6.75 mg 
2 capsules twice 
C4 Chaga extract (4:1) 300 mg; vitamin C 100 mg 1 capsule 2–3 times 
C5 Patented mixture (Aphanizomenon flos conc, Cordyceps extract, 
Undaria pinnatifida extract, Polygonum multiflorum extract) 
550 mg 
2 capsules 1–2 times 
C6 Reishi extract 180 mg; royal jelly 160 mg, grape seed extract 
(resveratrol) 100 mg; tomato extract (lycopene) 35 mg; broccoli 
extract (sulforaphane) 25 mg 
1 capsule 
C7 β-(1→3) glucan 30 mg; vitamin C 100 mg; vitamin E 30 IU; zinc 
20 mg; selenium 200 μg; arabinogalactan 1500 mg; Proprietary 
Blend® (Astragalus (root), Echinacea purpurea (leaf and stem), 
Elderberry Fruit) 150 mg 
1 capsule 
C8 Reishi extract 96 mg; chlorophyll 50 mg; lutein 16 mg; lycopene 7 
mg; grapefruit extract 30 mg; blueberry extract 30 mg 
1 capsule 
C9 Reishi extract 600 mg 2 capsules 
C10 Reishi extract powder (10:1) 45 mg; Reishi powder 150 mg; 
Shiitake extract powder (4:1) 75 mg 
2 capsules twice 
S1 β-(1→3) (1→6)-D-glucan 10 mg ml-1; vitamin C 10 mg ml-1 1–2 ml/5kg 
S2 β-(1→3) (1→6)-D-glucan 29.5 mg ml-1; vitamin C 10.25 mg ml-1; 
zinc 0.75 mg ml-1 
15 ml 
S3 Chinese cordyceps 75 %; Linchzhi (Ganoderma lucidum) 6 %; 
Shiitake 6 %; young bamboo shoots 5 %; honey 2 % 
3–5 ml daily 
P1 Maitake mushroom powder 300 mg three times 
P2 Reishi spore powder 300 mg three times 
P3 Chaga powder 100 % 1 teaspoon per 2 dl of 
water 3–5 times 
Diphenylpicrylhydrazyl (DPPH) radical scavenging microassay. The DPPH microassay 
was performed as described previously.24 Briefly, 7 μl of diluted extracts were mixed with 
193 μl of the DPPH radical solution (60 μM) in microplate wells. The absorbance readings 
were taken after 1 h of reaction at 490 nm on a MTP reader. Trolox was used in order to cons-
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truct the standard curve, and hence the results were expressed as μM TE per recommended 
daily doses for the mushroom-derived supplements and as μM TE per serving size for the shi-
itake mushrooms. 
Ferric ion reducing antioxidant power (FRAP) microassay. The antioxidant activity was 
determined using the FRAP microassay according to Bolanos et al. with some modific-
ations.25 The FRAP reagent was prepared by mixing acetate buffer (pH 3.6), TPTZ solution 
(2,4,6-tripyridyl-s-triazine in 40 mM HCl) and 20 mM FeCl3·6H2O in a 10:1:1 volume ratio. 
Aliquots of the extracts (20 μl) were allowed to react with 280 μl of FRAP reagent in a 
96-well microplate. After 30 min at 37 °C, the absorbance readings were taken at 630 nm on a 
MTP reader. A standard curve was constructed by Trolox and the results are expressed as 
μmol TE per recommended daily doses for the mushroom-derived supplements and as μM TE 
per serving size for the shiitake mushrooms. 
Cupric ion reducing antioxidant capacity (CUPRAC) microassay. This method was per-
formed according to Zengin et al. with modifications.26 After placing 67 μl of diluted extracts 
in a 96-well microplate, 61 μl of 0.01 M CuCl2, 61 μl of 7.5 μM neocuproine and 61 μl of 
ammonium acetate buffer (pH 7.0) were added. After 30 min of incubation, the absorbance 
was read against a reagent blank at 450 nm. Trolox was used to obtain a standard curve and 
the results are expressed as μM TE per recommended daily dose for the mushroom-derived 
supplements and as μM TE per serving size for the shiitake mushrooms. 
Antioxidant potency composite index (ACI). The results obtained from the in vitro anti-
oxidant assays (ABTS, DPPH, FRAP and CUPRAC) allowed the antioxidant composite index 
(ACI) to be calculated.27 An index value of 100 is assigned to the best score for each assay.  
An index score for all samples was calculated as follows: 
 Sample scoreAntioxidant index score 100
Best score
=   (1) 
The ACI values were created by averaging all four assays for each sample. 
Determination of β-glucan content 
The β-glucan content was quantified by a spectrophotometric method using the enzym-
atic assay kit K-YBGL (Megazyme, Bray, Wicklow County, Ireland) according to the manu-
facturer’s instructions. This assay combines hydrolysis steps with enzymatic incubation and 
determines total glucan as well as α-glucan content. The β-glucan content was calculated by 
subtracting the α-glucan content from the total glucan content. The total glucan fragments 
were quantitatively hydrolyzed to glucose using a mixture of exo-1,3-β-glucanase and α-glu-
cosidase. Afterwards, the α-glucans were specifically determined, by hydrolysis of the glucans 
to glucose, using amyloglucosidase plus amylase and later by glucose–oxidase–peroxidase 
determination (GOPOD) reagent. All measurements were performed at 510 nm. The results 
are expressed as grams of β-glucan per 100 g of the weighed samples and as milligrams of 
β-glucan per recommended daily doses for the mushroom-derived supplements, as well as per 
serving size for the shiitake mushrooms. 
Statistical analysis 
All analyses were performed in triplicate and the obtained results are presented as the 
mean values and the standard deviations (SD). The Spearman correlation coefficient was used 
to calculate the correlations between data. Statistical analyses were completed using the com-
puter program SPSS (version 20, Chicago, IL, USA) and a p value <0.05 was considered 
statistically significant. 
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Principal component analysis (PCA) was performed to identify and visualize relation-
ships between ACI of mushroom-derived supplements and their respective TPC, β-glucan and 
labeled content of vitamin C, per daily doses. PCA was performed with the software Past 3.25.28 
RESULTS AND DISCUSSION 
The results of the β-glucan content in the mushroom-derived food supple-
ments are summarized in Table II. They varied from 4.54 g (100 g)–1 (P3) to 
37.49 g (100 g)–1 (C8). These values are in accordance with those of a previous 
study,29 which revealed considerable differences in β-glucan content among 
commercial mushroom products. Namely, not only mushroom species and the 
type of mushroom materials, but also the manner of cultivation and the extraction 
procedures probably contribute to the observed variability.30 
TABLE II. β-Glucan and total polyphenol contents in food supplements and shiitake mush-
rooms 






mg GAE / dda 
C1 19.12±0.16 334.13±2.84 12.94±1.91 22.61±3.34 
C2 25.47±1.24 347.41±8.49 4.08±0.07 5.57±0.09 
C3 26.23±0.10 403.94±1.52 13.04±0.47 20.09±0.72 
C4 13.24±0.17 165.24±2.12 127.43±7.52 159.03±9.38 
C5 10.32±0.44 224.98±9.56 2.51±0.17 5.46±0.38 
C6 8.44±0.20 42.20±0.99 8.17±0.16 4.09±0.08 
C7 5.70±0.24 39.90±1.68 31.16±0.39 21.87±0.27 
C8 33.25±0.13 156.92±0.63 6.72±0.11 3.17±0.05 
C9 15.22±0.16 194.45±2.08 4.10±0.08 5.24±0.10 
C10 37.49±2.17 653.74±37.86 2.74±0.53 4.77±0.93 
S1 13.25±0.07 66.25±0.35 2.51±0.38 1.25±0.19 
S2 7.80±0.59 327.60±24.95 2.44±0.05 10.22±0.22 
S3 18.21±0.04 764.82±1.78 0.45±0.01 1.89±0.01 
P1 15.18±0.30 136.62±2.67 2.38±0.08 2.15±0.07 
P2 5.63±0.58 50.67±5.22 0.81±0.07 0.73±0.076 
P3 4.54±0.44 953.40±92.07 3.68±0.07 77.35±1.37 
shiitake 2.87±0.09 2078.21±64.08b 4.23±0.44 306.34±31.54b 
aDaily dose; bserving size (72.5 g) instead of daily dose 
Ganoderma lucidum (reishi) is known to have more than 200 different poly-
saccharides that are isolated from fruiting bodies, mycelium, spores or liquid cul-
tures.31 In recent years, there has been an increasing concern about the quality of 
reishi products.32 In an analysis of polysaccharide and triterpene profiles, Wu et 
al. found that only 26.3 % of the Ganoderma lucidum supplements were in 
accordance with their labels.18 This study also found significant variations in the 
β-glucan content among reishi supplements. The lowest β-glucan content was 
observed for sample P2 in the form of reishi spores powder. Within samples 
based on reishi fruiting bodies extracts, the β-glucan content ranged between 8.44 
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g (100 g)–1 (C6) and 33.25 g (100 g)–1 (C8), reflecting differences in the quali-
tative and quantitative composition among them.  
The dose of mushroom-based products in traditional medicine should cor-
respond to 100–150 g of raw material. However, the consensus for the effective 
dosage for mushroom supplements has not been established. According to clin-
ical trials, the accepted daily dose is 3000–6000 mg of biomass or mushroom 
extracts.16 When the obtained results were expressed per maximum daily doses 
established by manufactures, the content of β-glucan was up to 1000 mg with an 
average concentration of 293 mg (Table II). Chaga powder supplements (P3) 
provide the highest amount of β-glucan (953.40 mg dd–1), followed by mixed 
mushroom supplements S3 (764.82 mg dd–1) and C10 (653.74 mg dd–1), res-
pectively. These results indicate that mushroom supplements provide less β-glu-
cans intake than one serving size of shitake (2078.21 mg). 
Interestingly, the α-glucan contents in this study were low and ranged from 
0.13 to 2.32 g (100 g)–1 (data not shown in Table II). In contrast to earlier find-
ings,18,28 these results indicate the absence of starch-based excipients, such as 
starch or maltodextrins, as possible adulterants in the analyzed mushroom sup-
plements. 
Mushrooms are recognized as good sources of dietary polyphenols.33 Dep-
ending on the mushroom species, the total polyphenols content range from 1 to 6 
mg g–1 dried weight.34 In addition to antioxidative properties, numerous studies 
have revealed that mushroom phenolic compounds exert anti-inflammatory, anti-
microbial, anticancer, antiviral, neuroprotective and other health-promoting 
effects.35 The total phenolic contents ranged from 0.45 mg GAE g–1 (S3) to 
127.43 GAE g–1 (C4, Table II). Since many other, non-phenolic reducing com-
pounds may interfere in the Folin–Ciocalteu assay, by far the highest value of 
TPC in the extract of sample C4, in comparison with other extracts, could be 
explained by the high-labeled content of vitamin C. As expected, higher levels of 
TPC were noticed among mushroom extracts mixed with herbal materials (C1, 
C3 and C7). 
Similar to the β-glucan content, the difference in the polyphenol content 
among mushroom supplements could be due to different mushroom species, type 
of the mushroom product, as well as various processing factors, which makes 
comparison difficult. Stilinovic et al.36 studied the total phenolics of commercial 
preparations of edible mushrooms and showed that the methanol extract from the 
powder of Cordyceps sinensis contained three times more total phenolics than 
from Ganoderma lucidum. In this study, opposite results were obtained for sup-
plements from the same producers (C1 and C2), which contained the same quan-
tity of extracts of these mushroom species. When the recommended daily doses 
were taken into account, the average TPC in the analyzed mushroom supple-
ments was 21 mg GAE dd–1. The content of polyphenols in the sample C4 (159 
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mg GAE dd–1) corresponds to only half of the intake that can be obtained from a 
single serving of shiitake mushrooms. 
According to the prevalent consumption, it was estimated that food supple-
ments contribute 25 % to the total daily antioxidant intake.37 However, due to 
different origin, preparation processes, formulations and concentrations of their 
active ingredients, great variability in antioxidant capacity was revealed among 
the supplements.38 In order to extensively evaluate the antioxidant potential of 
mushroom-derived supplements, different assays based on the transfer of elec-
trons (DPPH, ABTS) and reducing power ability ferrous (FRAP) and cupric ions 
(CUPRAC) were employed. Taken into account the differences in the total unit 
mass and dosage regimen among different forms of supplements, the antioxidant 
activity was expressed per maximum daily dose recommended by the producers 
(Table III). Namely, based on the obtained results, the antioxidant activity was 
mathematically recalculated by one unit of products (gram or milliliter) and then 
multiplied by the maximum daily amount labeled on the product package. 
TABLE III. Antioxidant activity (μM TE) in maximum daily dose of food supplements and 
one serving of shiitake mushrooms  
Code FRAP DPPH ABTS CUPRAC 
C1 112.41±3.12 92.40±1.82 47.64±0.98 265.91±9.21 
C2 276.96±27.17 294.04±21.87 159.83±3.88 517.71±56.94 
C3 89.04±0.50 86.75±1.54 43.37±0.12 211.81±2.25 
C4 5380.86±136.93 4112.83±160.88 1766.32±1.99 8718.12±125.77 
C5 13.23±1.99 53.00±0.53 21.07±0.01 73.12±1.39 
C6 26.020.70 31.36±1.49 14.72±0.02 66.48±9.19 
C7 671.72±2.50 273.37±20.79 189.00±0.61 945.77±23.95 
C8 18.64±0.34 15.92±0.43 7.09±0.00 43.62±6.02 
C9 20.99±0.36 33.68±0.42 17.48±0.10 60.44±4.97 
C10 26.16±0.46 39.49±0.82 19.57±0.14 73.54±1.09 
S1 5.80±0.22 13.03±0.30 1.88±0.11 23.93±3.46 
S2 49.90±2.59 235.03±4.77 22.82±0.87 139.82±3.56 
S3 5.64±0.72 101.23±1.87 2.97±0.34 20.87±0.67 
P1 7.10±0.14 23.84±0.20 10.83±0.04 41.07±3.22 
P2 2.42±0.24 46.31±0.23 0.10±0.00 4.22±2.03 
P3 448.84±13.00 645.19±13.57 290.50±2.66 1905.96±18.83 
Shiitakeb 3102.28±452.16 1714.26±210.70 551.73±78.95 nda 
aNot determined; bserving size (72.5 g) instead of daily dose 
Since the results of antioxidant activity obtained by different assays are dif-
ficult to compare with one other,39 ACI values were calculated and presented in 
Fig. 1. 
Although the in vitro antioxidant capacity cannot be directly translated to 
biological systems, the ACI value presents a useful tool for ranking different 
commercial products.27 As could be seen, sample C4 had the highest ACI value, 
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followed by sample P3 and C7. A significant correlation was found between the 
TPC and ACI values (p < 0.001). However, no significant correlation between the 
β-glucan content and ACI, or with any of the antioxidant activities, was observed. 
Since that majority of the analyzed products are based on mushroom extracts, 
these results could be explained by the fact that purified polysaccharides, free of 
phenolic compounds and proteins, have a low antioxidant activity.40 Except for 
sample C4, one serving of shiitake provides better antioxidant potency than 
mushroom-based supplements. 
Fig. 1. Antioxidant composite indexes of 
mushroom-derived food supplements. 
According to the PCA results, two principal components were sufficient to 
capture the variability of the sample properties. The first component, represented 
as the x-axis, describes 71.06 % of the variability, whereas the second compo-
nent, represented as the y-axis, describes 26.77 % of the variability. For further 
analysis of the variability sources, scores and loadings were plotted and the bi-plot 
is represented in Fig. 2. The first component describes the majority of the vari-
ation between the samples and it is represented by a combination of the ACI 
value, total phenolic content and vitamin C per daily dose, since these three vari-
ables have a positive first component (i.e., x-axis) coordinates and, according to 
the values of the loadings, contribute to the first component. This is indicative of 
the positive correlation between these three variables, and it is demonstrative of 
the fact that the product C4 with the highest ACI had the highest TPC and labeled 
vitamin C content per daily dose. All products with positive x-axis coordinates 
have high ACI values. On the other hand, the remaining variability of the samples 
is described by the second component (i.e., y-axis), which is predominantly 
affected by the content of β-glucans per daily dose. Product samples that are pro-
jected on the positive side of the y-axis have higher β-glucans contents per daily 
dose. Sample P3, therefore, has a high amount of β-glucans and high ACI since it 
has positive values for both coordinates. Other samples are projected and 
grouped in the bi-plot according to their ACI and β-glucans content. With the inc-
rease of x-coordinate values, the content of ACI increases, whereas with increas-
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ing values of the y-coordinate, the content of β-glucans increases. The relative 
contribution of ACI, TPC, β-glucans and vitamin C content on the principal com-
ponents is represented in terms of their loadings values in Table IV. 
 
Fig. 2. Scores and loadings bi-plot. 
TABLE IV. Principal components (PC1 and PC2) loadings values  
Parameter PC1 PC2 
ACI / % 0.5892 –0.0060 
TPC / mg GAE dd-1 0.5679 0.2163 
β-glucans, mg/dd –0.0282 0.9630 
Vitamin C, mg/dd 0.5741 –0.1605 
CONCLUSIONS 
Mushroom-derived food supplements available on the Serbian market were 
analyzed for their β-glucan and phenolic contents, as well as antioxidant cap-
acities. Using PCA, the variability of daily doses in β-glucan content was less 
than in their antioxidant capacity. The addition of other active ingredients, such 
as vitamin C, has an impact on the antioxidant variability. In addition to the need 
for standardization for commercial mushroom-based products, the obtained 
results did not support the fact that usage of these products could contribute more 
β-glucan and dietary antioxidant intake than regular consumption of shiitake 
mushrooms as part of an optimal balanced diet. 
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И З В О Д  
АНАЛИЗА САДРЖАЈА БЕТА-ГЛУКАНА И АНТИОКСИДАТИВНА АКТИВНОСТ У 
ДОДАЦИМА ИСХРАНИ НА БАЗИ ГЉИВА 
МИЛИЦА ЗРНИЋ ЋИРИЋ1, НЕВЕНА ДАБЕТИЋ1, ВАЊА ТОДОРОВИЋ1, ЈЕЛЕНА ЂУРИШ2 и БОЈАНА ВИДОВИЋ1 
1Универзитет у Београду, Фармацеутски факултет, Катедра за Броматологију, Београд и 
2Универзитет у Београду, Фармацеутски факултет, Катедра за Фармацеутску технологију и 
козметологију, Београд 
Због присуства бројних биоактивних састојака, укључујући полисахариде и поли-
феноле, додаци исхрани на бази гљива имају бројне позитивне здравствене ефекте. 
Поред популарности, последњих година се велика пажња посвећује и квалитету произ-
вода од гљива, посебно у погледу њиховог нестандардизованог хемијског састава. У овом 
раду анализиран је садржај β-глукана и укупних полифенола, као и антиоксидативни 
потенцијал додатака исхрани на бази гљива који су доступни на тржишту Србије. Доби-
јени резултати су показали велике разлике у садржају β-глукана и укупних полифенола 
што се може објаснити различитим врстама гљива, облицима и режимима дозирања. 
Уочена је корелација између укупног садржаја полифенола и антиоксидативне актив-
ности. Присуство других биолошки активних састојака, као што је витамин Ц, допри-
нело је варијабилности антиоксидантне активности између анализираних производа. 
Добијени резултати указују на потребу за стандардизацијом додатака исхрани на бази 
гљива, како би се осигурао њихов ефекат. 
(Примљено 1. јула, ревидирано 11. октобра, прихваћено 4. новембра 2019) 
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